Weekly Recap: Barclays cuts price target and Q3 revenue declines

Beyond Meat reported Q3 gross profit of $12.4M, up from $5.2M YoY, with gross margin rising to 19.3%. U.S. and international revenues fell 12.3% and 2.8%, respectively. Barclays maintained its Underweight rating and cut its price target to $5 from $10.

Original reporting
Published Nov 9, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 1:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Weekly Recap: Barclays cuts price target and Q3 revenue declines — source image
Decision brief

The 30-second read

$BYNDBearishMed
01

Why it matters

The downgrade and price‑target cut suggest a bearish outlook, potentially prompting short positions or profit‑taking.

02

Market read

Earnings miss and analyst downgrade create short‑term downside risk for BYND and may influence sentiment in the alternative‑protein space.

03

What to watch

Cost reductions and international retail growth may offset short‑term volume declines.

Relevance 6/10Novelty 6/10Timing: post‑market reaction

Background

Beyond Meat is a publicly traded plant‑based meat substitute producer (NASDAQ: BYND). The article summarizes its Q3 results and a Barclays analyst downgrade.

Company-level read

Ticker impact

$BYNDBearishHigh confidence
Context

Beyond Meat reported Q3 gross profit and margin improvements, but sales volume fell and Barclays cut its price target to $5.

Expected impact

likely pressure as the market prices in the lower price target and weaker sales volume.

Evidence & confidence

The combination of falling sales volume and a 50% price‑target cut signals short‑term downside risk.

Market effects

Plant‑based protein sector may see broader scrutiny as analysts tighten targets.

U.S. consumer‑discretionary stocks could face modest sell pressure.

Limited to investors tracking alternative protein companies.

Counterpoint

Margin expansion could indicate a path to profitability if volume rebounds.

Key entities

  • Barclays

    Maintained Underweight rating and cut price target.

Related articles

$BYNDMed

Beyond Meat (BYND) Q3 2026 Earnings Call Transcript

Beyond Meat (BYND) reported Q3 2026 net revenues of $64.5M, down 8% YoY but stable sequentially. Gross margin improved to 19.3%, the highest in five years. The company is focusing on stabilizing its U.S. business, growing internationally, and driving operational efficiency. New products like Beyond Steak Filet and Ground Faba are showing early success.

$BYNDMed

Beyond Meat Inc (BYND) Q3 2026 Earnings Call Highlights: Margin Milestone Masks Revenue

Beyond Meat (BYND) reported Q3 2026 revenue of $64.5M, down 8.1% YoY, with declines across U.S. retail, foodservice, and international foodservice. Operating expenses were $105.4M, leading to a net loss of $82.8M. Gross margin improved to 19.3%, the highest in five years. Q4 revenue guidance is $54M-$59M. Management focuses on cost reduction and new product launches to stabilize the business.

$BYNDHighAI 8/10

What Beyond Meat (BYND) Said on Its Q3 Earnings Call

Beyond Meat reported Q3 sales volume down 10.9% but net revenue per pound up 3.2%. U.S. retail revenue fell 13.2% to $24.8M, while international retail revenue rose 13.3% to $17.9M. The company posted a net loss of $82.8M, narrower than last year's $97M loss. Adjusted EBITDA loss was $24.6M, improved from $33.5M a year earlier. Beyond Meat is focusing on stabilizing U.S. business and expanding into new products and markets.